The role of CXCR3 in the induction of primary biliary cirrhosis

Clinical and Developmental Immunology

Volumn 2011, Issue , 2011, Pages

  Zhang, Fengchun ^a   Zhang, Wen ^a   Fei, Yunyun ^a   Gao, Jinming ^a   Liu, Bin ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MITOCHONDRION ANTIBODY; POLYINOSINIC POLYCYTIDYLIC ACID; SMOOTH MUSCLE ANTIBODY; AUTOANTIBODY; CXCR3 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHOLANGITIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; LIVER; LIVER BIOPSY; LIVER FUNCTION TEST; LYMPHOCYTE; MOUSE; NONHUMAN; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; ANIMAL; BILIARY CIRRHOSIS; C57BL MOUSE; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LYMPHOCYTE COUNT; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

ANIMALS; AUTOANTIBODIES; CHOLANGITIS; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS, BILIARY; LYMPHOCYTE COUNT; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, ANIMAL; RECEPTORS, CXCR3;

EID: 79959258856     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2011/564062     Document Type: Article

References (34)

1. He X. S., Ansari A. A., Ridgway W. M., Coppel R. L., Gershwin M. E., New insights to the immunopathology and autoimmune responses in primary biliary cirrhosis Cellular Immunology 2006 239 1 1 13 (Pubitemid 43927662)
2. Sols Herruzo J. A., Sols Muoz P., Muoz Yage T., The pathogenesis of primary biliary cirrhosis Revista Espanola de Enfermedades Digestivas 2009 101 6 413 423
3. Shimoda S., Harada K., Niiro H., Taketomi A., Maehara Y., Tsuneyama K., Kikuchi K., Nakanuma Y., Mackay I. R., Gershwin M. E., Akashi K., CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosis Hepatology 2010 51 2 567 575
4. Colvin R. A., Campanella G. S. V., Sun J., Luster A. D., Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function Journal of Biological Chemistry 2004 279 29 30219 30227 (Pubitemid 38937947)
5. Lacotte S., Brun S., Muller S., Dumortier H., CXCR3, inflammation, and autoimmune diseases Annals of the New York Academy of Sciences 2009 1173 310 317
6. Lee E. Y., Lee Z. H., Song Y. W., CXCL10 and autoimmune diseases Autoimmunity Reviews 2009 8 5 379 383
7. Xie J. H., Nomura N., Lu M., Chen S. L., Koch G. E., Weng Y., Rosa R., Di Salvo J., Mudgett J., Peterson L. B., Wicker L. S., DeMartino J. A., Antibody-mediated blockade of the CXCR3 chemokine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation Journal of Leukocyte Biology 2003 73 6 771 780 (Pubitemid 38040456)
8. Ruth J. H., Rottman J. B., Katschke K. J., Qin S., Wu L., LaRosa G., Ponath P., Pope R. M., Koch A. E., Selective lymphocyte chemokine receptor expression in the rheumatoid joint Arthritis and Rheumatism 2001 44 12 2750 2760 (Pubitemid 34016194)
9. Gerard C., Rollins B. J., Chemokines and disease Nature Immunology 2001 2 2 108 115 (Pubitemid 33707927)
10. Balashov K. E., Rottman J. B., Weiner H. L., Hancock W. W., CCR5 and CXCR3 T cells are increased in multiple sclerosis and their ligands MIP-1 and IP-10 are expressed in demyelinating brain lesions Proceedings of the National Academy of Sciences of the United States of America 1999 96 12 6873 6878 (Pubitemid 29274977)
11. Norii M., Yamamura M., Iwahashi M., Ueno A., Yamana J., Makino H., Selective recruitment of CXCR3 + and CCR5 + CD4 + T cells into synovial tissue in patients with rheumatoid arthritis Acta Medica Okayama 2006 60 3 149 157 (Pubitemid 44298541)
12. Mohan K., Issekutz T. B., Blockade of chemokine receptor CXCR3 inhibits T cell recruitment to inflamed joints and decreases the severity of adjuvant arthritis Journal of Immunology 2007 179 12 8463 8469
13. Enghard P., Humrich J. Y., Rudolph B., Rosenberger S., Biesen R., Kuhn A., Manz R., Hiepe F., Radbruch A., Burmester G. R., Riemekasten G., CXCR3 + CD4 + T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients Arthritis and Rheumatism 2009 60 1 199 206
14. Wenzel J., Proelss J., Wiechert A., Zahn S., Bieber T., Tting T., CXCR3-mediated recruitment of cytotoxic lymphocytes in lupus erythematosus profundus Journal of the American Academy of Dermatology 2007 56 4 648 650 (Pubitemid 46400173)
15. Singh U. P., Venkataraman C., Singh R., Lillard J. W., CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication Endocrine, Metabolic and Immune Disorders 2007 7 2 111 123 (Pubitemid 46969859)
16. Martini G., Zulian F., Calabrese F., Bortoli M., Facco M., Cabrelle A., Valente M., Zacchello F., Agostini C., CXCR3/CXCL10 expression in the synovium of children with juvenile idiopathic arthritis Arthritis Research Therapy 2005 7 2 R241 R249
17. Wenzel J., Schmidt R., Proelss J., Zahn S., Bieber T., Tting T., Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis Clinical and Experimental Dermatology 2006 31 4 576 582 (Pubitemid 43806596)
18. Bauer J. W., Petri M., Batliwalla F. M., Koeuth T., Wilson J., Slattery C., Panoskaltsis-Mortari A., Gregersen P. K., Behrens T. W., Baechler E. C., Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study Arthritis and Rheumatism 2009 60 10 3098 3107
19. Helbig K. J., Ruszkiewicz A., Semendric L., Harley H. A. J., McColl S. R., Beard M. R., Expression of the CXCR3 Ligand I-TAC by Hepatocytes in Chronic Hepatitis C and Its Correlation with Hepatic Inflammation Hepatology 2004 39 5 1220 1229 (Pubitemid 38569043)
20. Zeremski M., Petrovic L. M., Chiriboga L., Brown Q. B., Yee H. T., Kinkhabwala M., Jacobson I. M., Dimova R., Markatou M., Talal A. H., Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C Hepatology 2008 48 5 1440 1450
21. Perney P., Turriere C., Portals P., Rigole H., Psomas C., Blanc F., Clot J., Corbeau P., CXCR3 expression on peripheral CD4 + T cells as a predictive marker of response to treatment in chronic hepatitis C Clinical Immunology 2009 132 1 55 62
22. Wald O., Weiss I. D., Galun E., Peled A., Chemokines in hepatitis C virus infection: pathogenesis, prognosis and therapeutics Cytokine 2007 39 1 50 62 (Pubitemid 47446256)
23. Larrubia J. R., Calvino M., Benito S., Sanz-de-Villalobos E., Perna C., Prez-Hornedo J., Gonzlez-Mateos F., Garca-Garzn S., Bienvenido A., Parra T., The role of CCR5/CXCR3 expressing CD8 + cells in liver damage and viral control during persistent hepatitis C virus infection Journal of Hepatology 2007 47 5 632 641 (Pubitemid 47503421)
24. Helbig K. J., Ruszkiewicz A., Lanford R. E., Berzsenyi M. D., Harley H. A., McColl S. R., Beard M. R., Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro Journal of Virology 2009 83 2 836 846
25. Biche I., Asselah T., Laurendeau I., Vidaud D., Degot C., Paradis V., Bedossa P., Valla D. C., Marcellin P., Vidaud M., Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection Virology 2005 332 1 130 144 (Pubitemid 40127235)
26. Harvey C. E., Post J. J., Palladinetti P., Freeman A. J., Ffrench R. A., Kumar R. K., Marinos G., Lloyd A. R., Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation Journal of Leukocyte Biology 2003 74 3 360 369 (Pubitemid 38040396)
27. Zeremski M., Petrovic L. M., Talal A. H., The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection Journal of Viral Hepatitis 2007 14 10 675 687 (Pubitemid 47414927)
28. Larrubia J. R., Benito-Martnez S., Calvino M., Sanz-de-Villalobos E., Parra-Cid T., Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection World Journal of Gastroenterology 2008 14 47 7149 7159
29. Holst P. J., Orskov C., Qvortrup K., Christensen J. P., Thomsen A. R., CCR5 and CXCR3 are dispensable for liver infiltration, but CCR5 protects against virus-induced T-cell-mediated hepatic steatosis Journal of Virology 2007 81 18 10101 10112 (Pubitemid 350067714)
30. Hokeness K. L., Deweerd E. S., Munks M. W., Lewis C. A., Gladue R. P., Salazar-Mather T. P., CXCR3-dependent recruitment of antigen-specific T lymphocytes to the liver during murine cytomegalovirus infection Journal of Virology 2007 81 3 1241 1250 (Pubitemid 46167845)
31. Chuang Y. H., Lian Z. X., Cheng C. M., Lan R. Y., Yang G. X., Moritoki Y., Chiang B. L., Ansari A. A., Tsuneyama K., Coppel R. L., Gershwin M. E., Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives Journal of Autoimmunity 2005 25 2 126 132 (Pubitemid 41608556)
32. Harada K., Nakanuma Y., Molecular mechanisms of cholangiopathy in primary biliary cirrhosis Medical Molecular Morphology 2006 39 2 55 61 (Pubitemid 44576783)
33. Cruise M. W., Lukens J. R., Nguyen A. P., Lassen M. G., Waggoner S. N., Hahn Y. S., Fas ligand is responsible for CXCR3 chemokine induction in CD4 + T cell-dependent liver damage Journal of Immunology 2006 176 10 6235 6244
34. Okada C., Akbar F., Horiike N., Onji M., Early development of primary biliary cirrhosis in female C57BL/6 mice because of poly I:C administration Liver International 2005 25 3 595 603 (Pubitemid 40861909)